Estelle Black 10/19/22 Estelle Black 10/19/22

MedWorld Advisors Hosts Panels at MPO Summit 2022

MedWorld Advisors hosts panel at MPO Summit 2022: Shifting Manufacturing: Is Nearshoring the Answer for MedTech?

Estelle Black 10/11/22 Estelle Black 10/11/22

MedTech M&A In 2022: Is It Still A Sellers’ Market?

Is it still a sellers’ market? While 2020 and 2021 showed robust MedTech M&A, Florence Joffroy-Black and Dave Sheppard take a look at MedTech M&A in 2022 and as we head toward 2023 in this webinar produced by Today’s Medical Development.

Estelle Black 10/6/22 Estelle Black 10/6/22

Commercialization: Building & Managing Distribution Channels in APAC vs. US

Co-Founder/Managing Director Dave Sheppard guest speaks on MedTech Innovator APAC’s webinar discussing building and managing distribution channels in the MedTech sector.

MedWorld Advisors 9/26/22 MedWorld Advisors 9/26/22

How To Maximize Value To Potential MedTech Buyers

It is necessary to understand the different types of buyers and how they can get the most value for their enterprises.

MedWorld Advisors 9/13/22 MedWorld Advisors 9/13/22

Top 10 Issues To Consider To Create Value

Pathway to strategic partnerships or exit for early-stage or middle-market MedTech companies.

Estelle Black 9/2/22 Estelle Black 9/2/22

Dave Sheppard Guest Speaker at Medical Manufacturing Asia 2022

Managing Director Dave Sheppard presented “M&A Exit Strategies and International Commercialization Through Strategic Acquirers/Partners” at Medical Manufacturing Asia 2022.

MedWorld Advisors 8/24/22 MedWorld Advisors 8/24/22

Considering The Impacts of Industry Strategics

Top 6 ways MedTech’s giants influence all of us.

MedWorld Advisors 7/21/22 MedWorld Advisors 7/21/22

Trends Impacting the Top 30 Companies (and Everyone Else)

While there are a myriad of issues affecting healthcare development and delivery, the most impactful remain more or less the same.

MedWorld Advisors 7/12/22 MedWorld Advisors 7/12/22

Obtaining Strategic Partnerships

Top 7 items to address to win a larger partner for growth opportunities.

MedWorld Advisors 6/15/22 MedWorld Advisors 6/15/22

The Impacts of SPACs, M&A, and Divestitures on OEM Suppliers

Medtech companies have orchestrated many noteworthy portfolio moves in recent years, creating interesting market dynamics.

Florence Joffroy-Black 6/10/22 Florence Joffroy-Black 6/10/22

Value = Strategic Fit +Timing ®

How do you define the value of a business? CEO Florence Joffroy-Black outlines what factors impact valuation.

MedWorld Advisors 6/7/22 MedWorld Advisors 6/7/22

MWA Facilitates Deal: HOPCo Partners with Future Health Works to Acquire Musculoskeletal Patient Engagement and Outcomes Tracking Platform

Partnership aims to create the world’s largest integrated MSK data platform

MedWorld Advisors 5/27/22 MedWorld Advisors 5/27/22

Industry observations from MD&M West

Industry observations from MD&M West: Supply chain - From just in time to just need it!

Daniel Sheppard 5/20/22 Daniel Sheppard 5/20/22

Making Your Dream Team A Reality

Selling your business can be a daunting task with a lot of unknowns for first time sellers. Make sure you’re prepared for the best outcome by putting in place an experienced team that can help manage your exit process appropriately.

MedWorld Advisors 5/16/22 MedWorld Advisors 5/16/22

Valuation = Strategic Fit + Timing®!

What is the value of your medtech business?

Estelle Black 5/9/22 Estelle Black 5/9/22

Want to Sell Your Healthcare Business Now Or In The Near Future? Are You Ready? Take It Back To The Start.

Every step you’ve taken in the process of building a company now has an impact when it comes to selling. The start is no exception. Be sure to pay attention to these questions that began at the start of your company as they will become important as you move along in the selling process.

MedWorld Advisors 5/4/22 MedWorld Advisors 5/4/22

M&A in Turbulent Times—Bullish or Bearish?

M&A deal volume in the medical device contract manufacturing market rebounded dramatically last year, reaching a record $1.6 billion. But it remains to be seen how long the 2021 M&A recovery will last—will 2022’s deal value top last year’s or will the upturn lose steam as the seasons progress and the world grapples with lingering supply chain issues, 40-year-high inflation (U.S.), and an increasingly bloody war in Ukraine?

Estelle Black 4/27/22 Estelle Black 4/27/22

Daniel Sheppard to Speak at 10X Conference in San Diego, CA

Daniel Sheppard to speak at the 10X Conference in San Diego, CA May 12, 2022.

MedWorld Advisors 4/13/22 MedWorld Advisors 4/13/22

What’s Your Ukraine Strategy?

What you do for Ukraine matters to all of us!

MedWorld Advisors 4/5/22 MedWorld Advisors 4/5/22

Strategy or Tactics—What Should be the Focus for Medtech in 2022?

Successful business executives know strategy is important, but they also understand the most effective plans focus on winning methods. So what should be the focus for Medtech in 2022? Strategy or tactics?

Contact us.